Drug hope for people with common heart thickening disease

A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease.

The TEMPEST trial, led by University of Manchester researchers, tested the drug—called trientine—in 154 adults with the condition in a yearlong, placebo-controlled study.

The study is published in the European Heart Journal. ...